Indrayani Biotech bulk deals, insider trading and stake changes
BSE: 526445Agricultural Food & other ProductsSmall Cap
Last close ₹8.34down ₹0.43 (4.90%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹8.77.
52-week range of traded prices to 23 Oct 2026
₹6.10Low, 19 Mar 2026₹16.47High, 6 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹38 Cr3,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 Sep 2026
- 0.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Oct 2026
- 1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 Sep 2026
- 1.26
- Volume, BSEVolume. Shares traded on the last trading day.
- 19,910
Indrayani Biotech insider trading
All 12 disclosures on record. The company's own latest disclosure on record is from Jul 2022.Insider trading, all companies
Jun 2022
- Thirumeni Thiruselvaraju₹0.62 Cr3,09,389 sharesGave · Promoter · 30 Jun 2022 · Off Market · stake 3.53% before, 2.63% after
- V Agathiyan₹2.05 Cr10,25,000 sharesGave · Promoter · 27 Jun 2022 · disclosed 29 Jun · Off Market · stake 5.04% before, 2.05% after
Mar 2022
- Thirumeni Thiruselvaraja₹0.75 Cr3,91,000 sharesGave · Promoter Group · 3 Mar 2022 · disclosed 14 Mar · Market · holds 12,46,989 after, stake 3.64% after
Sep 2020
- G.Swaminathan41,40,000sharesReceived · Director · 16 Sep 2020 · disclosed 18 Sep · Scheme of Amalgamation/Merger/Demerger/Arrangement · held none before, holds 41,40,000 after
- Sayee Sundar Kasiraman0sharesReceived · Promoter · 16 Sep 2020 · disclosed 18 Sep · Scheme of Amalgamation/Merger/Demerger/Arrangement · held 26,31,569 before, holds 26,31,569 after
- Singarababu Indirakumar20,98,600sharesReceived · Director · 16 Sep 2020 · disclosed 18 Sep · Scheme of Amalgamation/Merger/Demerger/Arrangement · held none before, holds 20,98,600 after
Jan 2018
- Anuj Prakash Bang (Revised)₹0.01 Cr1,28,400 sharesGave · Promoter · 2 Jan 2018 · disclosed 4 Jul · SPA & Open Offer · held 1,28,400 before
- Smita Jhavar (Revised)₹22,00020,000 sharesGave · Promoter · 2 Jan 2018 · disclosed 4 Jul · SPA & Open Offer · held 20,000 before
- Malti Ramchandra Bang (Revised)₹0.02 Cr1,62,400 sharesGave · Promoter · 2 Jan 2018 · disclosed 4 Jul · SPA & Open Offer · held 1,62,400 before
- Ruchir Prakash Bang (Revised)₹0.01 Cr1,28,400 sharesGave · Promoter & Director · 2 Jan 2018 · disclosed 4 Jul · SPA & Open Offer · held 1,28,400 before
- Prakash Ramchandra Bang (Revised)₹0.17 Cr15,44,400 sharesGave · Promoter & Director · 2 Jan 2018 · disclosed 4 Jul · SPA & Open Offer · held 15,44,400 before
- Vrunda Prakash Bang (Revised)₹0.02 Cr1,80,400 sharesGave · Promoter · 2 Jan 2018 · disclosed 4 Jul · SPA & Open Offer · held 1,80,400 before
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Indrayani Biotech stake sales and purchases
All 11 disclosures on record.
Jun 2022
- SoldV Agathiyan · promoter2.99% of the company10,25,000 sharesholds 2.05% after29 Jun 2022 · filed under the 2% rule · Off Market
Sep 2020
- AcquiredIndira Kumar S & PACs · promoter20.45% of the company70,00,000 sharesholds 20.45% after16 Sep 2020 · filed under the 5% rule · Merger
- AcquiredG. Swaminathan & PACs · promoter22.61% of the company77,40,000 sharesholds 22.61% after16 Sep 2020 · filed under the 5% rule · Allotment
Jul 2018
- AcquiredK SayeeSundar59.39% of the company21,64,000 sharesholds 72.22% after6 Jul 2018 · filed under the 2% rule · Open Offer
- SoldSmita Jhavar · promoter0.55% of the company20,000 shares4 Jul 2018 · filed under the 2% rule · Share purchase agreement
- SoldAnuj Prakash Bang · promoter3.52% of the company1,28,400 shares4 Jul 2018 · filed under the 2% rule · Share purchase agreement
- SoldRuchir Prakash Bang · promoter3.52% of the company1,28,400 shares4 Jul 2018 · filed under the 2% rule · Share purchase agreement
- SoldMalti Ramchandra Bang · promoter4.46% of the company1,62,400 shares4 Jul 2018 · filed under the 2% rule · Share purchase agreement
- SoldVrunda Prakash Bang · promoter4.95% of the company1,80,400 shares4 Jul 2018 · filed under the 2% rule · Share purchase agreement
- SoldPrakash Ramchandra Bang · promoter42.38% of the company15,44,400 shares4 Jul 2018 · filed under the 2% rule · Share purchase agreement
Apr 2018
- AcquiredSayee Sundar Kasiraman12.83% of the company4,67,569 sharesholds 12.83% after4 Apr 2018 · filed under the 5% rule · Share purchase agreement
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Indrayani Biotech bulk deals
Last 12 months, since 23 Oct 2025: 2 bulk deals, ₹0.92 Cr bought and ₹0.46 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 5 Jun 20262 firms · ₹0.46 Cr bought · ₹0.46 Cr soldNet nil
- SoldAMBA INVESTORS AOPSold 4,00,000 at ₹11.450.88% of the company₹0.46 Cr
- BoughtVITRAG SEVENTEEN FAMILY TRUSTBought 4,00,000 at ₹11.450.88% of the company₹0.46 Cr
Thursday 6 Nov 20251 firm · ₹0.46 Cr bought · ₹0 soldNet bought ₹0.46 Cr
- BoughtGURURAJ PRIYADARSHINIBought 3,00,944 at ₹15.440.66% of the company₹0.46 Cr
Friday 28 Mar 20252 firms · ₹0.42 Cr bought · ₹0.35 Cr soldNet bought ₹0.07 Cr
- BoughtPARIMALA KRISHNAMURTHYBought 2,98,500 at ₹14.140.66% of the company₹0.42 Cr
- SoldNEXT ORBIT VENTURES FUNDSold 2,50,000 at ₹14.140.55% of the company₹0.35 Cr
Thursday 27 Mar 20251 firm · ₹0.37 Cr bought · ₹0 soldNet bought ₹0.37 Cr
- BoughtLRSD SECURITIES PRIVATE LIMITEDBought 2,50,000 at ₹14.820.55% of the company₹0.37 Cr
Thursday 27 Jun 20244 firms · ₹7.68 Cr bought · ₹8.26 Cr soldNet sold ₹0.58 Cr
- SoldNEXT ORBIT VENTURES FUNDSold 10,00,000 at ₹58.862.20% of the company₹5.89 Cr
- BoughtRAJASTHAN GLOBAL SECURITIES PRIVATE LIMITEDBought 9,52,945 at ₹58.602.09% of the company₹5.58 Cr
- SoldSAHASTRAA ADVISORS PRIVATE LIMITEDSold 2,67,714 at ₹58.600.59% of the company₹1.57 Cr
- Both waysTOPGAIN FINANCE PRIVATE LIMITEDBought 3,51,626 at ₹59.46Sold 1,37,325 at ₹58.600.77% of the companyNet +2,14,301 shares₹2.09 Cr bought
Wednesday 26 Jun 20241 firm · ₹1.58 Cr bought · ₹0 soldNet bought ₹1.58 Cr
- BoughtSAHASTRAA ADVISORS PRIVATE LIMITEDBought 2,67,714 at ₹59.110.59% of the company₹1.58 Cr
Wednesday 5 Jul 20231 firm · ₹0 bought · ₹1.27 Cr soldNet sold ₹1.27 Cr
- SoldNEXT ORBIT VENTURES FUNDSold 2,00,000 at ₹63.420.58% of the company₹1.27 Cr
Tuesday 4 Jul 20231 firm · ₹0 bought · ₹1.21 Cr soldNet sold ₹1.21 Cr
- SoldBOUGAINVILLEA INVESTMENTS PRIVATE LIMITEDSold 1,93,747 at ₹62.500.57% of the company₹1.21 Cr
Wednesday 14 Sep 20221 firm · ₹0 bought · ₹3.14 Cr soldNet sold ₹3.14 Cr
- SoldNEXT ORBIT VENTURES FUNDSold 2,98,475 at ₹105.140.87% of the company₹3.14 Cr
Tuesday 30 Aug 20222 firms · ₹1.40 Cr bought · ₹2.82 Cr soldNet sold ₹1.42 Cr
- SoldNEXT ORBIT VENTURES FUNDSold 4,00,000 at ₹70.481.17% of the company₹2.82 Cr
- BoughtGUNAVANTHKUMAR G VAIDBought 1,99,672 at ₹70.220.58% of the company₹1.40 Cr
Wednesday 24 Aug 20225 firms · ₹4.20 Cr bought · ₹5.40 Cr soldNet sold ₹1.20 Cr
- SoldNEXT ORBIT VENTURES FUNDSold 6,20,000 at ₹55.201.81% of the company₹3.42 Cr
- BoughtINDIA EQUITY FUND 1Bought 3,50,000 at ₹55.001.02% of the company₹1.93 Cr
- BoughtMITTAL CLOTHING COMPANYBought 2,12,800 at ₹55.000.62% of the company₹1.17 Cr
- SoldSRINIVASAN KANNANSold 1,75,000 at ₹55.720.51% of the company₹0.98 Cr
- Both waysMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 2,00,333 at ₹55.15Sold 1,80,333 at ₹55.610.59% of the companyNet +20,000 shares₹1.10 Cr bought
Monday 31 May 20211 firm · ₹0.03 Cr bought · ₹0.10 Cr soldNet sold ₹0.07 Cr
- Both waysBOUGAINVILLEA INVESTMENTS PRIVATE LIMITEDBought 54,000 at ₹5.79Sold 1,77,000 at ₹5.620.52% of the companyNet −1,23,000 shares₹0.03 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 24 deals on record from 4 Jan 2004.